XML 103 R87.htm IDEA: XBRL DOCUMENT v3.6.0.2
Selected Quarterly Financial Data (Unaudited) (Detail) - USD ($)
$ / shares in Units, shares in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Revenues:                      
Product revenues $ 617,000 $ 709,000 $ 856,000 $ 1,301,000 $ 2,045,000 $ 2,251,000 $ 3,116,000 $ 2,610,000 $ 3,483,000 $ 10,022,000 $ 12,917,000
Research and development programs 4,219,000 3,601,000 3,592,000 3,587,000 3,348,000 2,266,000 3,433,000 3,784,000 14,999,000 12,831,000 23,045,000
Total revenues 4,836,000 4,310,000 4,448,000 4,888,000 5,393,000 4,517,000 6,549,000 6,394,000 18,482,000 22,853,000 35,962,000
Costs and operating expenses:                      
Cost of product revenues 2,218,000 884,000 850,000 1,304,000 2,788,000 2,411,000 3,014,000 2,350,000 5,256,000 10,563,000 12,866,000
Research and development 6,901,000 7,708,000 8,276,000 8,231,000 9,586,000 13,207,000 12,747,000 12,554,000 31,116,000 48,094,000 81,680,000
Sales, general and administrative 10,096,000 11,169,000 10,834,000 11,642,000 14,075,000 15,143,000 16,411,000 16,412,000 43,741,000 62,041,000 72,621,000
Restructuring charges (43,000) 216,000 49,000 1,190,000 4,581,000 (21,000) (31,000) 424,000 1,412,000 4,953,000 3,514,000
Total costs and operating expenses 19,172,000 19,977,000 20,009,000 22,367,000 31,030,000 30,740,000 32,141,000 31,740,000 81,525,000 125,651,000 170,681,000
Loss from continuing operations before other income (expense): (14,336,000) (15,667,000) (15,561,000) (17,479,000) (25,637,000) (26,223,000) (25,592,000) (25,346,000) (63,043,000) (102,798,000) (134,719,000)
Other income (expense):                      
Interest and other income, net (2,544,000) (2,898,000) (3,157,000) (3,116,000) (3,314,000) (3,047,000) (3,534,000) (3,300,000)      
Loss from equity method investments (5,783,000) (6,378,000) (5,358,000) (4,872,000) (4,098,000) (5,916,000) (7,309,000) (5,066,000) (22,391,000) (22,389,000) (23,037,000)
Debt conversion expense (4,743,000) (3,242,000) (1,785,000) 0 0 0 0 0 (9,770,000) 0 (1,766,000)
Total other expense, net (13,070,000) (12,518,000) (10,300,000) (7,988,000) (7,412,000) (8,963,000) (10,843,000) (8,366,000) (43,876,000) (35,584,000) (26,442,000)
Loss from continuing operations before income taxes (27,406,000) (28,185,000) (25,861,000) (25,467,000) (33,049,000) (35,186,000) (36,435,000) (33,712,000) (106,919,000) (138,382,000) (161,161,000)
Benefit from income taxes (223,000) (1,839,000) 0 0 0 0 0 0 (2,062,000) 0 0
Loss from continuing operations (27,183,000) (26,346,000) (25,861,000) (25,467,000) (33,049,000) (35,186,000) (36,435,000) (33,712,000) (104,857,000) (138,382,000) (161,161,000)
Income (loss) from discontinued operations 71,000 5,852,000 (1,577,000) (1,045,000) (1,644,000) 268,000 (736,000) (953,000) 3,301,000 (3,065,000) (980,000)
Net loss $ (27,112,000) $ (20,494,000) $ (27,438,000) $ (26,512,000) $ (34,693,000) $ (34,918,000) $ (37,171,000) $ (34,665,000) $ (101,556,000) $ (141,447,000) $ (162,141,000)
Net income (loss) per share from continuing operations, per basic and diluted share (in dollars per share) $ (0.30) $ (0.31) $ (0.31) $ (0.31) $ (0.41) $ (0.44) $ (0.45) $ (0.43) $ (1.22) $ (1.73) $ (2.13)
Net income (loss) from discontinued operations, per basic and diluted share (in dollars per share) 0.00 0.07 (0.02) (0.01) (0.02) 0.01 (0.01) (0.01) 0.04 (0.03) (0.01)
Net loss per share, basic and diluted (in dollars per share) $ (0.30) $ (0.24) $ (0.33) $ (0.32) $ (0.43) $ (0.43) $ (0.46) $ (0.44) $ (1.18) $ (1.76) $ (2.14)
Weighted-average number of shares used in loss per share computation:                      
Basic and diluted (in shares) 91,582 85,837 84,380 81,950 80,600 80,298 80,098 79,650 85,952 80,165 75,879